Equillium officer proposes $316K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Equillium, Inc. officer Christine Zedelmayer reported a proposed sale of 185,937 common shares, with an aggregate market value of $316,092 and an approximate sale date of February 19, 2026. The listed acquisition entries show 109,375 shares acquired from the issuer through stock options on January 12, 2022, and 76,562 on January 2, 2024; both list cash as the nature of payment. The Rule 10b5-1 section gives August 27, 2025 as the plan-adoption or instruction date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Gross Proceeds financial
Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What plan date is listed for EQ officer Christine Zedelmayer?
What recent EQ stock sales by Christine Zedelmayer are listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.